Evidence map›Paper›PMID 36212176›Full record

ArticleDisease markers2022

Prognostic Value of an Integrin-Based Signature in Hepatocellular Carcinoma and the Identification of Immunological Role of LIMS2.

Fengning Ye, Hao Le, Fan He, Hao Tu, Dengfa Peng, Sini Ruan

Open access · hybridAbstract read
In one paragraph

Article in Disease markers, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.3field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 2 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Fengning YeUltrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Hao LeFirst Surgical Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Fan HeUltrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Hao TuUltrasound Imaging Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.
Dengfa PengFirst Surgical Department, The National Hospital of Enshi Autonomous Prefecture, Enshi, China.ORCID https://orcid.org/0000-0002-2302-7295
Sini RuanUltrasound Imaging Department I, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.ORCID https://orcid.org/0000-0002-9913-7247
The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: Evidence proves that integrins affect almost every step of hepatocellular carcinoma (HCC) progression. The current study aimed at constructing an integrin-based signature for prognostic prediction of HCC. Methods: TCGA-LIHC and ICGC-LIRI-JP cohorts were retrospectively analyzed. Integrin genes were analyzed via univariate Cox regression, followed by generation of a prognostic signature with LASSO approach. Independent factors were input into the nomogram. WGCNA was adopted to select this signature-specific genes. Gene Ontology (GO) enrichment together with Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis were conducted to explore the function of the dysregulated genes. The abundance of tumor microenvironment components was estimated with diverse popular computational methods. The relative importance of genes from this signature was estimated through random-forest method. Results: Eight integrin genes (ADAM15, CDC42, DAB2, ITGB1BP1, ITGB5, KIF14, LIMS2, and SELP) were adopted to define an integrin-based signature. Each patient was assigned the riskScore. High-riskScore subpopulation exhibited worse overall survival, with satisfying prediction efficacy. Also, the integrin-based signature was independent of routine clinicopathological parameters. The nomogram (comprising integrin-based signature, and stage) accurately inferred prognostic outcome, with the excellent net benefit. Genes with the strongest positive interaction to low-riskScore were primarily linked to biosynthetic, metabolic, and catabolic processes and immune pathways; those with the strongest association with high-riskScore were principally associated with diverse tumorigenic signaling. The integrin-based signature was strongly linked with tumor microenvironment components. Among the genes from this signature, LIMS2 possessed the highest importance, and its expression was proven through immunohistochemical staining. Conclusion: Altogether, our study defined a quantitative integrin-based signature that reliably assessed HCC prognosis and tumor microenvironment features, which possessed the potential as a tool for prognostic prediction.

Indexed as

Carcinoma, HepatocellularLiver NeoplasmsADAM ProteinsAdaptor Proteins, Signal TransducingBiomarkers, TumorGene Expression ProfilingGene Expression Regulation, NeoplasticHumansIntegrinsKaplan-Meier EstimateLIM Domain ProteinsMembrane ProteinsPrognosisRetrospective StudiesTumor MicroenvironmentADAM15 protein, humanADAM ProteinsAdaptor Proteins, Signal TransducingBiomarkers, TumorIntegrinsLIM Domain ProteinsLIMS2 protein, humanMembrane Proteins

Identifiers

PMID36212176
PMCPMC9537015
OpenAlexW4297982994

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.